Cargando…
Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer
OBJECTIVE: The aim of the present study was to assess patient compliance with tyrosine kinase inhibitor (TKI) treatment used for refractory and progressive thyroid cancer, in addition to the efficacy and serious adverse events associated with these agents. METHODS: We retrospectively analyzed data f...
Autores principales: | Chrisoulidou, Alexandra, Mandanas, Stylianos, Margaritidou, Efterpi, Mathiopoulou, Lemonia, Boudina, Maria, Georgopoulos, Konstantinos, Pazaitou-Panayiotou, Kalliopi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562763/ https://www.ncbi.nlm.nih.gov/pubmed/26366098 http://dx.doi.org/10.2147/OTT.S86322 |
Ejemplares similares
-
Loss of Efficacy of Pasireotide After its Re-Administration: is There a Reason Why?
por: Mandanas, Stylianos, et al.
Publicado: (2016) -
Breast Metastasis from Medullary Thyroid Carcinoma in a Male Patient: Case Report and Review of the Literature
por: Mandanas, Stylianos, et al.
Publicado: (2015) -
Acute adrenal insufficiency following arthroplasty: a case report and review of the literature
por: Mandanas, Stylianos, et al.
Publicado: (2013) -
Parathyroid involvement in thyroid cancer: an unforeseen event
por: Chrisoulidou, Alexandra, et al.
Publicado: (2012) -
Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancer
por: Chrisoulidou, Alexandra, et al.
Publicado: (2011)